BioVaria brings together Europe’s top scientists and technology transfer professionals with potential licensees and investors from the international biopharmaceutical industry. Top-tier academic institutions and universities from all over Europe will present over 60 attractive partnering and investment opportunities in the life-science field.
- Unparalleled density of highly innovative commercial opportunities
- 15 technology transfer partners from five European countries
- 10 life-science startups from Austria, Czech Republic, Denmark, Germany and Norway participating in this year’s Startup Pitch and Partner event
- Interactive panel discussion on “From stem cells to therapy: Development of cell based approaches in regenerative medicine” moderated by Dr Martin Raditsch, CEO, Innovectis GmbH.
Register here www.biovaria.org.
Further information: